Stock Analysis on Net

Elevance Health Inc. (NYSE:ELV)

$24.99

Balance Sheet: Liabilities and Stockholders’ Equity
Quarterly Data

The balance sheet provides creditors, investors, and analysts with information on company resources (assets) and its sources of capital (its equity and liabilities). It normally also provides information about the future earnings capacity of a company assets as well as an indication of cash flows that may come from receivables and inventories.

Liabilities represents obligations of a company arising from past events, the settlement of which is expected to result in an outflow of economic benefits from the entity.

Paying user area

The data is hidden behind: . Unhide it.

This is a one-time payment. There is no automatic renewal.


We accept:

Visa Mastercard American Express Maestro Discover JCB PayPal Google Pay
Visa Secure Mastercard Identity Check American Express SafeKey

Elevance Health Inc., consolidated balance sheet: liabilities and stockholders’ equity (quarterly data)

US$ in millions

Microsoft Excel
Mar 31, 2026 Dec 31, 2025 Sep 30, 2025 Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Medical claims payable
Other policyholder liabilities
Unearned income
Accounts payable and accrued expenses
Short-term borrowings
Current portion of long-term debt
Other current liabilities
Liabilities held for sale
Current liabilities
Long-term debt, less current portion
Deferred tax liabilities, net
Other noncurrent liabilities
Noncurrent liabilities
Total liabilities
Preferred stock, without par value; shares issued and outstanding: none
Common stock, par value $0.01
Additional paid-in capital
Retained earnings
Accumulated other comprehensive loss
Shareholders’ equity
Noncontrolling interests
Total equity
Total liabilities and equity

Based on: 10-Q (reporting date: 2026-03-31), 10-K (reporting date: 2025-12-31), 10-Q (reporting date: 2025-09-30), 10-Q (reporting date: 2025-06-30), 10-Q (reporting date: 2025-03-31), 10-K (reporting date: 2024-12-31), 10-Q (reporting date: 2024-09-30), 10-Q (reporting date: 2024-06-30), 10-Q (reporting date: 2024-03-31), 10-K (reporting date: 2023-12-31), 10-Q (reporting date: 2023-09-30), 10-Q (reporting date: 2023-06-30), 10-Q (reporting date: 2023-03-31), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31), 10-K (reporting date: 2021-12-31), 10-Q (reporting date: 2021-09-30), 10-Q (reporting date: 2021-06-30), 10-Q (reporting date: 2021-03-31).


The balance sheet reflects a period of significant expansion in both total liabilities and total equity, with total liabilities and equity increasing from $95.68 billion in March 2021 to $125.83 billion by March 2026. While both components grew, the growth in total liabilities outpaced the growth in total equity, indicating a strategic increase in leverage to support organizational operations.

Liability Structure and Trends
Total liabilities rose from $61.77 billion to $81.79 billion over the analyzed period. A primary driver of this increase was the steady growth in medical claims payable, which expanded from $12.35 billion to $18.43 billion. Long-term debt, excluding the current portion, also exhibited a clear upward trajectory, rising from $22.53 billion in early 2021 to $30.77 billion by March 2026. Current liabilities showed a parallel upward trend, increasing from $34.75 billion to $45.31 billion, largely influenced by the growth in medical claims payable and other current liabilities.
Equity and Retained Earnings
Total equity grew from $33.92 billion to $44.04 billion. This growth was primarily fueled by a consistent increase in retained earnings, which climbed from $24.79 billion to $35.80 billion, suggesting sustained profitability and the retention of earnings over the five-year horizon. Additional paid-in capital remained relatively stable, fluctuating between $8.69 billion and $9.25 billion, indicating a lack of significant new equity issuance.
Comprehensive Loss and Volatility
Accumulated other comprehensive loss exhibited significant volatility throughout the period. The loss peaked in September 2022 at $2.78 billion before showing a gradual recovery trend through 2024 and 2025, eventually settling at $741 million in March 2026. This pattern suggests susceptibility to market-driven fluctuations, likely related to investment valuations or currency translation adjustments.
Debt Obligations and Liquidity Management
Debt management patterns show periodic shifts between short-term and long-term obligations. The current portion of long-term debt experienced peaks of $3.10 billion in March 2022 and $2.90 billion in March 2024, before decreasing to $350 million by March 2026, suggesting a cycle of debt maturity and refinancing. Short-term borrowings remained generally low, with a notable peak of $1.58 billion in December 2023, before returning to lower levels.